New York, New York, United States The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.
The high activity for fund was in 2015. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2017. Opposing the other organizations, this WFD Ventures works on 4 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the WFD Ventures, startups are often financed by New York Angels, F2 Ventures, Blackfin Technology. The meaningful sponsors for the fund in investment in the same round are Avista Capital Partners, General Catalyst, The Entrepreneurs' Fund. In the next rounds fund is usually obtained by Avista Capital Partners, Entrepreneurs Fund, ZGC Shiner Investment.
Among the most successful fund investment fields, there are Software, Biotechnology. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight BionXu2122 Medical Technologies, ProterixBio, ImaCor.
The fund was created by William F. Doyle.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Dainippon Sumitomo Pharma | Japan, Osaka, Osaka Prefecture |
| Diehl Ventures | Bayern, Germany, Nuremberg |
| eCatalogs | California, Los Angeles, United States |
| Foresight 4 VCT plc | - |
| Hankang Capital | China, Shanghai |
| Security Pacific National Bank | California, Los Angeles, United States |
| Wolverine Trading | Chicago, Illinois, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OptiNose | $30M | 06 Oct 2015 | Oslo | ||
OptiNose | $35M | 05 Aug 2014 | Oslo | ||
BionX™ Medical Technologies | $20M | 21 Oct 2009 | Massachusetts, United States | ||
ImaCor | $5M | 21 Feb 2009 | New York, United States | ||
NanoPass Technologies | $6M | 18 Feb 2007 | North District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OptiNose | $30M | 06 Oct 2015 | Oslo | ||
OptiNose | $35M | 05 Aug 2014 | Oslo | ||
BionX™ Medical Technologies | $20M | 21 Oct 2009 | Massachusetts, United States | ||
ImaCor | $5M | 21 Feb 2009 | New York, United States | ||
NanoPass Technologies | $6M | 18 Feb 2007 | North District |
